HealthDay: Is new clot-busting medication better treatment for...
February 3, 2022
HealthDay featured University of Cincinnati's Dr. Joseph Broderick in an article discussing a new clot-busting drug that may be safer when treating strokes.
February 3, 2022
HealthDay featured University of Cincinnati's Dr. Joseph Broderick in an article discussing a new clot-busting drug that may be safer when treating strokes.
February 3, 2022
Long before Intel announced the largest-ever investment in the sate of Ohio with a planned $20 billion chip manufacturing facility, the University of Cincinnati educated one of the corporation's former VPs, now known as the "Father of the Pentium."
February 3, 2022
Scientists using 20 years of research to lessen the impact of brain injury
February 3, 2022
HealthDay featured University of Cincinnati's Dr. Joseph Broderick in an article discussing a new clot-busting drug that may be safer when treating strokes.
February 3, 2022
Long before Intel announced the largest-ever investment in the sate of Ohio with a planned $20 billion chip manufacturing facility, the University of Cincinnati educated one of the corporation's former VPs, now known as the "Father of the Pentium."
February 3, 2022
Scientists using 20 years of research to lessen the impact of brain injury
February 3, 2022
The University of Cincinnati Blue Ash College is pleased to welcome Temesha Corbin as the new assistant dean of academic affairs.
February 3, 2022
The University of Cincinnati’s Carl H. Lindner College of Business and the Withrow University High School of Business have established the Withrow University High School of Business Pathway to Lindner College of Business program, which will prepare Withrow students for higher education — more specifically in business areas of study.
February 2, 2022
One-quarter of UC’s nearly 7,000 faculty and staff have already contributed to the 2021-22 Faculty & Staff Campaign, putting the goal of 45% participation within reach.
February 2, 2022
In early 2020, after COVID-19 moved classes online, the University of Cincinnati implemented a pass/fail option. This allowed students who were worried about the effect of a low grade on their GPA to choose to have their instructor either pass or fail them, thus ensuring that remote learning wouldn’t reflect on their record. (Separated the ideas up a bit) The College of Arts & Sciences was one of the first colleges to adopt the pass/fail option, and eventually, each college on UC’s campus would adopt the policy. The A&S Tribunal, the College of Arts & Sciences’ student-led governing body, was instrumental in the implementation of this policy. Isabel Slonneger, Vice President of the A&S Tribunal, recalls the purpose of the pass/fail initiative: “Tribunal is for advocating on behalf of students,” she says. Pass/fail has been vital for students, especially those who do not thrive in an online learning environment. The pass/fail initiative is only one of many initiatives that the A&S Tribunal spearheads. As the student government for the College of Arts & Sciences, the Tribunal works to represent students and their needs and make changes that will benefit both. Any A&S student can join the Tribunal, and it’s one step closer to making connections, new friends and changes that matter on UC’s campus. (nut graf)
February 2, 2022
These UC College of Nursing faculty and staff have stepped into interim leadership roles while the college searches for its next dean.
February 2, 2022
Voice of America featured the University of Cincinnati's Dr. Maria Espinola in a story about the connection between pandemic stress and an increase in traffic accident and overdose deaths.
February 2, 2022
Former School of Human Services doctorate student, Kamonta Heidelberg, shares the importance behind his research and the need for more black males in the School of Psychology field.
February 2, 2022
Due to the predicted winter storm, Hoxworth Blood Center will close all Neighborhood Donor Centers and Blood Drives on Thursday, February 3.
February 2, 2022
The University of Cincinnati's Chad Zender is leading a clinical trial studying if using a combination of Cesium-131 radioactive seeds and immunotherapy can be more effective and provide better quality of life than current treatments for patients with recurrent head and neck cancer.
February 1, 2022
UC faculty member authors report on Cincinnati's climate equity factors.
February 1, 2022
On Jan. 31, 2022, police responded to the 2700 block of Euclid Avenue for a burglary report.
February 1, 2022
Professor Jeffery Blevins on combating misinformation in the digital age.